Located primarily at the periphery of the tumor, these aggregates of CD3+ and CD8+ T cells and CD163+ macrophages provided further evidence that metastatic PNETs were associated with more immune activation than localized tumors, even at the primary tumor site (Figure 4E), suggesting tumor-specific differences in T cell recruitment. The gene discussed is CD163; the disease is neoplasm.